Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that the U.S. Food and Drug ...

The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has added ...

In 2007, a group of American researchers discovered a new, very rare type of amyloidosis — one that targets a person’s kidneys. (1) Like other forms of amyloidosis, this newly discovered type involves ...

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the most ...

When Sally Cox was diagnosed with light chain amyloidosis (AL) in 2019, she was shocked. Not only had she never heard of the rare disease that causes abnormal proteins (or amyloids) to build up in ...

Amyloidosis is classified into three main forms depending on the cause of the condition. The condition is also referred to as either localized when only one site of the body is affected, or systemic ...

In people with a rare condition called light chain amyloidosis, light chain proteins—which are a component of antibodies—mutate and build up in different organs. In new research published in The FEBS ...

Lisa Ferrero was diagnosed with AL amyloidosis and multiple myeloma at age 56. After 10 years, a clinical trial of CAR-T ...

Amyloidosis is the term applied to a group of conditions caused by deposits of an abnormal protein called amyloid. This rare but serious condition affects between 1 and 5 people in every 100,000 each ...

Your DNA is composed of over 20,000 “coding genes,” which determine pretty much everything to do with your body and mind — from the color of your hair follicles to your cells’ ability to repair and ...